The Outdoor Diaries: Climbing Mountains and Removing Barriers with Nick Allen
By Codi Darnell September 28, 2021 Welcome to our blog series: The Outdoor Diaries. This series is about exploring the natural world from the perspective of people with chronic conditions and/or mobility issues. While the benefits of nature are for everybody, access to it isn’t always quite as simple. Motivation comes in many forms. What […]
NervGen Pharma Grants Stock Options
Vancouver, Canada. September 14, 2021 – NervGen Pharma Corp. (TSX-V: NGEN) (OTCQX: NGENF) (“NervGen” or the “Company”), a clinical stage biotech company dedicated to creating innovative solutions for the treatment of nervous system damage, today announced that the Company has granted 550,000 incentive stock options to Directors exercisable at a price of $2.10 per share […]
A Glimpse into the Paralympics
By Codi DarnellSeptember 14, 2021 The Olympic rings – it is an easily identifiable symbol that signifies the continents coming together to compete at the Olympic Games. But this iconic image says more than that. Without using any words, the interlocking circles are known worldwide to represent strength, competition, and athleticism at the highest level. […]
NervGen Pharma Presenting at the H.C. Wainwright 23rd Annual Global Investment Conference
Vancouver, Canada. September 12, 2021 – NervGen Pharma Corp. (TSX-V: NGEN) (OTCQX: NGENF) (“NervGen” or the “Company”), a clinical stage biotech company dedicated to developing innovative solutions for the treatment of nervous system damage, will be presenting at the H.C. Wainwright 23rd Annual Global Investment Conference, being held virtually on September 13-15, 2021. The presentation will […]
NervGen Pharma Announces Results of Annual General Meeting of Shareholders
Vancouver, Canada. September 10, 2021 – NervGen Pharma Corp. (TSX-V: NGEN) (OTCQX: NGENF) (“NervGen” or the “Company”), a clinical stage biotech company dedicated to developing innovative solutions for the treatment of nervous system damage today announces the results of its Annual General Meeting of Shareholders (“AGM”) held on September 9, 2021. “We are very pleased […]
Chasing Dreams After Disability – Meet The Stubborn Baker
By Codi Darnell August 31, 2021 How many people can look at their chosen career and say “I chased my dream”? For someone with a disability, breaking into the working world can be a challenge at the best of times, but chasing a dream that’s been labelled “not for you” has the potential to truly […]
NervGen Pharma Provides an Operational Update on its Ongoing Phase 1 Clinical Trial and Reports Second Quarter 2021 Results
Vancouver, Canada. August 19, 2021 – NervGen Pharma Corp. (TSX-V: NGEN; OTCQX: NGENF) (“NervGen” or the “Company”), a clinical stage biotech company dedicated to developing innovative solutions for the treatment of nervous system damage, today is providing an update on its Phase I clinical trial and is reporting its financial results for the second quarter […]
Peer Support and Spinal Cord Injury: A Look at the Documentary “Re-Inventing the Wheel”
By Codi Darnell August 17, 2021 People come into our lives at different times for different reasons. We connect with them based on mutual interests or shared experiences, forming relationships that help us to feel less alone in the world. Mothers need other mothers, fathers need other fathers, and people with spinal cord injuries (“SCI”) […]
NervGen Pharma and Massachusetts General Hospital Collaborate on Preclinical Studies in Alzheimer’s Disease / Dr. Ksenia Kastanenka to Study NVG-291’s Potential to Promote Repair in Alzheimer’s Disease Models
Vancouver, Canada. August 9, 2021 – NervGen Pharma Corp. (TSX-V: NGEN) (OTCQX: NGENF) (“NervGen” or the “Company”), a clinical stage biotech company dedicated to creating innovative solutions for the treatment of nervous system damage, announced today it has entered into a research collaboration with Dr. Ksenia Kastanenka of Massachusetts General Hospital (MGH) to study the […]
NervGen Pharma Corp. Closes Non-Brokered Private Placement
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Vancouver, Canada. August 5, 2021— NervGen Pharma Corp. (TSX-V: NGEN; OTCQX: NGENF) (“NervGen” the “Company”), a clinical stage biotech company dedicated to creating innovative solutions for the treatment of nervous system damage, is pleased to announce that it has closed a […]